Literature DB >> 18398036

Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.

Gretchen M Kreizenbeck1, Aaron J Berger, Antonio Subtil, David L Rimm, Bonnie E Gould Rothberg.   

Abstract

BACKGROUND: The need for novel molecular prognostic markers that can supplement validated clinicopathologic correlates for cutaneous malignant melanoma is well recognized. Proteins that mediate the epithelial-mesenchymal transition, the process by which a cancer cell disengages from its parent tumor, are important candidates.
METHODS: The prognostic relevance of E-cadherin, N-cadherin, and P-cadherin, calcium-dependent transmembrane glycoproteins that regulate cell-cell adhesion, and their adaptors, alpha-catenin, beta-catenin, and p120-catenin, was evaluated on a cohort of 201 primary and 274 metastatic melanoma tumors using fluorescence-based immunohistochemical methods and Automated Quantitative Analysis of protein expression on digitally captured photomicrographs.
RESULTS: Increasing levels of N-cadherin expression improved overall survival (log-rank = 7.31; P = 0.03) but did not retain significance following adjustment for established clinicopathologic correlates (P = 0.50). Higher levels of E-cadherin approached significance for favorable prognosis on both univariate (P = 0.13) and multivariable (P = 0.10) analyses. Hierarchical clustering of the composite profiles for all six markers identified four unique clusters that yielded differential overall survival (log-rank = 10.54; P = 0.01). Cluster 4, expressing high E-cadherin and N-cadherin levels, possessed the most favorable outcome and cluster 2, featuring low E-cadherin and alpha-catenin but modest N-cadherin, showed least favorable outcomes. Cluster 2 remained significant on multivariable analysis (hazard ratio, 3.29; 95% confidence interval, 1.50-7.19; P = 0.003).
CONCLUSIONS: Although none of the cadherin-based adhesion molecules were independently prognostic, multimarker profiles were significant. Similar to epithelial-derived tumors, loss of E-cadherin correlates with poor outcome. In contrast, for neural crest-derived cutaneous malignant melanoma, N-cadherin overexpression can be associated with either a successful epithelial-mesenchymal transition or a favorably differentiated tumor. Additional cadherin profiles are needed to discriminate these distinctive phenotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398036      PMCID: PMC3312613          DOI: 10.1158/1055-9965.EPI-07-2729

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  42 in total

1.  Long-term preservation of antigenicity on tissue microarrays.

Authors:  Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

2.  Functional implication of truncated P-cadherin expression in malignant melanoma.

Authors:  Richard Bauer; Anja Katrin Bosserhoff
Journal:  Exp Mol Pathol       Date:  2006-08-17       Impact factor: 3.362

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.

Authors:  R Bauer; P J Wild; S Meyer; F Bataille; A Pauer; M Klinkhammer-Schalke; F Hofstaedter; A K Bosserhoff
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

5.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.

Authors:  D A Dillon; T D'Aquila; A B Reynolds; E R Fearon; D L Rimm
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Authors:  Gunhild M Maelandsmo; Ruth Holm; Jahn M Nesland; Øystein Fodstad; Vivi Ann Flørenes
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

9.  Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.

Authors:  Eric Kielhorn; Elayne Provost; Drew Olsen; Thomas G D'Aquila; Bradley L Smith; Robert L Camp; David L Rimm
Journal:  Int J Cancer       Date:  2003-02-20       Impact factor: 7.396

Review 10.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

View more
  27 in total

1.  Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo.

Authors:  Kyle A DiVito; Valerie A Trabosh; You-Shin Chen; Yu Chen; Chris Albanese; Delphine Javelaud; Alain Mauviel; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-25       Impact factor: 4.693

2.  Melanoma prognostic model using tissue microarrays and genetic algorithms.

Authors:  Bonnie E Gould Rothberg; Aaron J Berger; Annette M Molinaro; Antonio Subtil; Michael O Krauthammer; Robert L Camp; William R Bradley; Stephan Ariyan; Harriet M Kluger; David L Rimm
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 3.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

Review 4.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

5.  HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42.

Authors:  Emhonta Johnson; Darcie D Seachrist; Carlos M DeLeon-Rodriguez; Kristen L Lozada; John Miedler; Fadi W Abdul-Karim; Ruth A Keri
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

6.  Divergent roles of p120-catenin isoforms linked to altered cell viability, proliferation, and invasiveness in carcinogen-induced rat skin tumors.

Authors:  Rong Wang; Ying-Shiuan Chen; Wan-Mohaiza Dashwood; Qingjie Li; Christiane V Löhr; Kay Fischer; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

7.  Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.

Authors:  Daniela Murtas; Cristina Maxia; Andrea Diana; Luca Pilloni; Claudia Corda; Luigi Minerba; Sara Tomei; Franca Piras; Caterina Ferreli; Maria Teresa Perra
Journal:  Histochem Cell Biol       Date:  2017-08-21       Impact factor: 4.304

Review 8.  Tissue prognostic biomarkers in primary cutaneous melanoma.

Authors:  Mario Mandalà; Daniela Massi
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

9.  Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors:  Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

10.  E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.

Authors:  Lorena Lobos-González; Lorena Aguilar; Jorge Diaz; Natalia Diaz; Hery Urra; Vicente A Torres; Veronica Silva; Christopher Fitzpatrick; Alvaro Lladser; Keith S Hoek; Lisette Leyton; Andrew F G Quest
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-11       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.